MTOR and cancer: Canagliflozin strongly inhibits oxidative phosphorylation and reduces ATP production, resulting in the inhibition of mTOR, which suppresses cell proliferation, inhibits the cell cycle in the G1 phase, and induces apoptosis in cancer cells.